S. Gawlak

发表

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

D. Auclair, P. Vincent, G. Bollag, 2004, Cancer Research.

Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture.

H. P. Fell, S. Gawlak, D. Chace, 1997, Bioconjugate chemistry.

Novel Interactions between Urokinase and Its Receptor*

J. Weisel, A. Mazar, K. Bdeir, 2000, The Journal of Biological Chemistry.

Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.

W. Hadden, A. Mazar, D. Cines, 2002, American journal of respiratory and critical care medicine.

Receptor Tyrosine Kinases Involved in Tumor Progression Activity and Targets the RAF/MEK/ERK Pathway and BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor

D. Auclair, P. Vincent, G. Bollag, 2004 .

Immunotoxins as cancer chemotherapeutic agents

S. Gawlak, D. Chace, B. Mixan, 1995 .

The Single-Chain Immunotoxins BR96 sFv-PE40 and BR96 sFv-PE38: Potent Anti-Tumor Agents for the Treatment of Human Cancer

P. Friedman, S. Gawlak, D. Chace, 1993 .

BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells.

P. Friedman, J. Brown, S. Gawlak, 1993, Cancer research.

Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.

J. Brown, S. Gawlak, C. Siegall, 1992, Bioconjugate chemistry.

Construction, Expression, and Characterization of BD1-G28-5 sFv, a Single-chain Anti-CD40 Immunotoxin Containing the Ribosome-inactivating Protein Bryodin 1*

S. Gawlak, J. A. Francisco, C. Siegall, 1997, The Journal of Biological Chemistry.

Homodimeric forms of bombesin act as potent antagonists of bombesin on Swiss 3T3 cells.

P. Kiener, S. Gawlak, R. Greenfield, 1991, Growth factors.

In vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins.

I. Pastan, S. Gawlak, D. Chace, 1994, Bioconjugate chemistry.

Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.

I. Pastan, S. Gawlak, C. Siegall, 1993, Bioconjugate chemistry.

Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica.

H. Klei, H. Einspahr, S. Gawlak, 1997, Biochemistry.

Identification of a specific tyrosine residue in Bryodin 1 distinct from the active site but required for full catalytic and cytotoxic activity

R. Dodge, S. Gawlak, C. Siegall, 1998, Protein science : a publication of the Protein Society.

Lymphoid organ weights and organ: body weight ratios of growing beagles

S. Gawlak, T. J. Yang, T. J. Yang, 1989, Laboratory animals.

Optimization of immunotherapy with adriamycin(hydrazone)-immunoconjugates in human B-lymphoma xenografts

S. Gawlak, G. Spitalny, A. Daues, 1991 .

Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates.

S. Gawlak, H. Marquardt, D. Chace, 1994, Bioconjugate chemistry.

A Region in Domain II of the Urokinase Receptor Required for Urokinase Binding*

A. Mazar, D. Cines, K. Bdeir, 2000, The Journal of Biological Chemistry.

Construction, Expression, and Characterization of BD1-G28-5 sFv, a Single-chain Anti-CD40 Immunotoxin Containing the Ribosome-inactivating Protein Bryodin 1*

S. Gawlak, J. A. Francisco, C. Siegall, 1997, The Journal of Biological Chemistry.

The in vitro effects of three lysosomotropic detergents against three human tumor cell lines

S. Gawlak, G. Dubowchik, R. Firestone, 1995 .

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

D. Auclair, P. Vincent, G. Bollag, 2004, Cancer Research.